Lifileucel plus Pembrolizumab
IOV-MEL-301
Phase 3 mab active
Quick answer
Lifileucel plus Pembrolizumab for Metastatic Melanoma is a Phase 3 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Metastatic Melanoma
- Phase
- Phase 3
- Modality
- mab
- Status
- active